A detailed history of Retirement Planning CO Of New England, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Retirement Planning CO Of New England, Inc. holds 19,383 shares of ABBV stock, worth $3.49 Million. This represents 1.95% of its overall portfolio holdings.

Number of Shares
19,383
Previous 19,306 0.4%
Holding current value
$3.49 Million
Previous $3.31 Million 15.58%
% of portfolio
1.95%
Previous 1.83%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $12,615 - $15,348
77 Added 0.4%
19,383 $3.83 Million
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $47,520 - $55,493
307 Added 1.62%
19,306 $3.31 Million
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $1.27 Million - $1.44 Million
-7,921 Reduced 29.42%
18,999 $3.46 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $70,313 - $79,189
511 Added 1.93%
26,920 $4.17 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $618,922 - $716,493
4,633 Added 21.28%
26,409 $3.94 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $271,512 - $337,880
2,049 Added 10.39%
21,776 $2.93 Million
Q1 2023

Apr 21, 2023

BUY
$144.61 - $166.54 $7,953 - $9,159
55 Added 0.28%
19,727 $3.14 Million
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $53,525 - $64,191
387 Added 2.01%
19,672 $3.18 Million
Q3 2022

Oct 19, 2022

BUY
$134.21 - $153.93 $25,768 - $29,554
192 Added 1.01%
19,285 $2.59 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $12,385 - $15,746
-90 Reduced 0.47%
19,093 $2.92 Million
Q1 2022

May 06, 2022

SELL
$131.98 - $163.75 $3,035 - $3,766
-23 Reduced 0.12%
19,183 $3.11 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $2.06 Million - $2.61 Million
19,206 New
19,206 $2.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Retirement Planning CO Of New England, Inc. Portfolio

Follow Retirement Planning CO Of New England, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Planning CO Of New England, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Retirement Planning CO Of New England, Inc. with notifications on news.